A pharmacist based intervention to improve the care of patients with CKD: A pragmatic, randomized, controlled trial

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Cooney, Danielle ^a   Moon, Helen ^a   Liu, Yang ^b   Miller, Richard Tyler ^c   Perzynski, Adam ^b,d   Watts, Brook ^a,b   Drawz, Paul E ^e  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Care management; Chronic disease; Hypertension; Medical informatics; Randomized trials

Indexed keywords

ANTIHYPERTENSIVE AGENT; PARATHYROID HORMONE;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; ADULT; AMBULATORY CARE; CLINICAL PRACTICE; COMPARATIVE STUDY; COMPLICATION; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; MORTALITY; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PROGRAM EVALUATION; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED STATES;

ADULT; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; FEMALE; HOSPITALS, VETERANS; HUMANS; HYPERTENSION; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PHARMACISTS; PRACTICE PATTERNS, PHYSICIANS'; PRAGMATIC CLINICAL TRIALS AS TOPIC; PRIMARY HEALTH CARE; PROGRAM EVALUATION; QUALITY IMPROVEMENT; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84927771835     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0052-2     Document Type: Article

References (34)

1. Drawz P, Rahman M. In the clinic. Chronic kidney disease. Ann Intern Med. 2009;150(3):ITC2-1-15; quiz ITC12-16.
2. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17-28.
3. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001, 37(1 Suppl 1):S137-181
4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-266.
5. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42(4 Suppl 3):S1-201.
6. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004, 43(5 Suppl 1):S1-290.
7. Hoy T, Fisher M, Barber B, Borker R, Stolshek B, Goodman W. Adherence to K/DOQI practice guidelines for bone metabolism and disease. Am J Manag Care. 2007;13(11):620-5.
8. Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55(3):441-51.
9. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988 -1994). Arch Intern Med. 2001;161(9):1207-16.
10. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J, et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16(5):1449-55.
11. Demakis JG, Beauchamp C, Cull WL, Denwood R, Eisen SA, Lofgren R, et al. Improving residents' compliance with standards of ambulatory care: results from the VA Cooperative Study on Computerized Reminders. JAMA. 2000;284(11):1411-6.
12. Ash JS, Sittig DF, Campbell EM, Guappone KP, Dykstra RH. Some unintended consequences of clinical decision support systems. AMIA Annu Symp Proc 2007:26-30
13. Thomas KG, Thomas MR, Stroebel RJ, McDonald FS, Hanson GJ, Naessens JM, et al. Use of a registry-generated audit, feedback, and patient reminder intervention in an internal medicine resident clinic - a randomized trial. J Gen Intern Med. 2007;22(12):1740-4.
14. Reed M, Huang J, Graetz I, Brand R, Hsu J, Fireman B, et al. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus. Ann Intern Med. 2012;157(7):482-9.
15. Abdel-Kader K, Fischer GS, Li J, Moore CG, Hess R, Unruh ML. Automated Clinical Reminders for Primary Care Providers in the Care of CKD: A Small Cluster-Randomized Controlled Trial. Am J Kidney Dis. 2011;58(6):894-902.
16. Drawz PE, Miller RT, Singh S, Watts B, Kern E. Impact of a chronic kidney disease registry and provider education on guideline adherence - a cluster randomized controlled trial. BMC Med Inform Decis Mak. 2012;12(1):62.
17. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64-78.
18. Levey AS, Greene T, Kusek J, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828.
19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter., Suppl. 2013; 3: 1-150. In.
20. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.
21. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329-38.
22. Wallace LS, Rogers ES, Roskos SE, Holiday DB, Weiss BD. Brief report: screening items to identify patients with limited health literacy skills. J Gen Intern Med. 2006;21(8):874-7.
23. Barrett BJ, Garg AX, Goeree R, Levin A, Molzahn A, Rigatto C, et al. A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol. 2011;6(6):1241-7.
24. van Zuilen AD, Bots ML, Dulger A, van der Tweel I, van Buren M, Ten Dam MA, et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int. 2012;82(6):710-7.
25. Isbel NM, Haluska B, Johnson DW, Beller E, Hawley C, Marwick TH. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J. 2006;151(3):745-53.
26. Mendu ML, Schneider LI, Aizer AA, Singh K, Leaf DE. Lee TH. Implementation of a CKD Checklist for Primary Care Providers. Clin J Am Soc Nephrol: Waikar SS; 2014.
27. Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, van Buren M, Ten Dam MA, et al. Nurse Practitioner Care Improves Renal Outcome in Patients with CKD. J Am Soc Nephrol. 2014;25(2):390-8.
28. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review. Nephrol Dial Transplant. 2012;27(1):276-92.
29. Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23(12):1966-72.
30. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):1996-2002.
31. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46-56.
32. Heisler M, Hofer TP, Schmittdiel JA, Selby JV, Klamerus ML, Bosworth HB, et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012;125(23):2863-72.
33. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol. 2006;26(5):503-10.
34. Houston TK, Allison JJ, Sussman M, Horn W, Holt CL, Trobaugh J, et al. Culturally appropriate storytelling to improve blood pressure: a randomized trial. Ann Intern Med. 2011;154(2):77-84.